MDT Stock Overview
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 3/6 |
Past Performance | 2/6 |
Financial Health | 5/6 |
Dividends | 5/6 |
Rewards
Risk Analysis
MDT passed our risk checks.
Medtronic plc Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$75.59 |
52 Week High | US$83.06 |
52 Week Low | US$65.32 |
Beta | 0.78 |
1 Month Change | -3.05% |
3 Month Change | -7.16% |
1 Year Change | -7.39% |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -29.98% |
Recent News & Updates
Recent updates
Shareholder Returns
MDT | AT Medical Equipment | AT Market | |
---|---|---|---|
7D | 2.2% | -0.03% | 1.3% |
1Y | -7.4% | -0.4% | 5.1% |
Return vs Industry: MDT underperformed the Austrian Medical Equipment industry which returned -0.5% over the past year.
Return vs Market: MDT underperformed the Austrian Market which returned 5.1% over the past year.
Price Volatility
MDT volatility | |
---|---|
MDT Average Weekly Movement | 2.1% |
Medical Equipment Industry Average Movement | 5.8% |
Market Average Movement | 3.5% |
10% most volatile stocks in AT Market | 5.1% |
10% least volatile stocks in AT Market | 1.7% |
Stable Share Price: MDT has not had significant price volatility in the past 3 months.
Volatility Over Time: MDT's weekly volatility (2%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1949 | 95,000 | Geoff Martha | www.medtronic.com |
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products.
Medtronic plc Fundamentals Summary
MDT fundamental statistics | |
---|---|
Market cap | €100.76b |
Earnings (TTM) | €3.90b |
Revenue (TTM) | €30.02b |
25.8x
P/E Ratio3.4x
P/S RatioIs MDT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
MDT income statement (TTM) | |
---|---|
Revenue | US$32.32b |
Cost of Revenue | US$11.08b |
Gross Profit | US$21.24b |
Other Expenses | US$17.04b |
Earnings | US$4.20b |
Last Reported Earnings
Jan 26, 2024
Next Earnings Date
May 23, 2024
Earnings per share (EPS) | 3.16 |
Gross Margin | 65.72% |
Net Profit Margin | 13.00% |
Debt/Equity Ratio | 48.3% |
How did MDT perform over the long term?
See historical performance and comparison